← Back
Funded Research & Clinical Trials
Reversible Dysfunction of Retinal Ganglion Cells in Glaucoma
Kostic M. (Data analysis, screening, recruitment, participant), “Reversible Dysfunction of Retinal Ganglion Cells in Glaucoma”, Sponsored by NIH/NEI 2R01EY014957 (Porciatti) 05/01/2014 -04/30/2018, $225,000 DC.